OTC Branding Distinction Could Gain From Recent Rx Trademark Litigation
This article was originally published in The Tan Sheet
Executive Summary
AstraZeneca wins a temporary restraining order preventing Dr. Reddy’s from marketing an all-purple generic of the proton pump inhibitor Nexium. OTC switch application consultant Susan Lavine Coleman says the decision “sends a strong warning to future OTC private label manufacturers”